Impact of depression and fatigue on relapsing remitting multiple sclerosis in Kingdom of Saudi Arabia

References

1. ↵
   1. Mohebi N,
   2. Moghaddasi M,
   3. Zaribafian M

   (2015) Relapsing remitting multiple sclerosis in an Iranian patient with neurofibromatosis type I. Neurol Int 7:5966.

   OpenUrl
2. ↵
   1. Barone DA,
   2. Singer BA,
   3. Merkov L,
   4. Rametta M,
   5. Suarez G

   (2016) Survey of US patients with multiple sclerosis:Comparison of the new electronic interferon beta-1b autoinjector (BETACONNECTTM) with mechanical autoinjectors. Neurol Ther 5:155–167.

   OpenUrl
3. ↵
   1. Geisseler O,
   2. Nyffeler T,
   3. Linnebank M,
   4. Pflugshaupt T

   (2016) Cognitive Impairment in Multiple Sclerosis:Clinical Manifestation, Neuroimaging Correlates, and Treatment. Semin Neurol 36:203–211.

   OpenUrl
4. ↵
   1. Morandi E,
   2. Tarlinton RE,
   3. Gran B

   (2015) Multiple Sclerosis between Genetics and Infections:Human Endogenous Retroviruses in Monocytes and Macrophages. Front Immunol 6:647.

   OpenUrl
5. ↵
   1. Lublin FD

   (2007) The incomplete nature of multiple sclerosis relapse resolution. J Neurol Sci 256:S14–S18.

   OpenUrlCrossRefPubMed
6. ↵
   1. Richards RG,
   2. Sampson FC,
   3. Beard SM,
   4. Tappenden P

   (2002) A review of the natural history and epidemiology of multiple sclerosis:implications for resource allocation and health economic models. Health Technol Assess (Rockv) 6:1–73.

   OpenUrlCrossRef
7. ↵
   1. Razaz N,
   2. Tremlett H,
   3. Boyce T,
   4. Guhn M,
   5. Marrie RA,
   6. Joseph KS

   (2016) Incidence of mood or anxiety disorders in children of parents with multiple sclerosis. Paediatr Perinat Epidemiol 30:356–366.

   OpenUrl
8. ↵
   1. Polychroniadou E,
   2. Bakirtzis C,
   3. Langdon D,
   4. Lagoudaki R,
   5. Kesidou E,
   6. Theotokis P,
   7. et al.

   (2016) Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in Greek population with multiple sclerosis. Mult Scler Relat Disord 9:68–72.

   OpenUrl
9. ↵
   1. Mohammadi K,
   2. Rahnama P,
   3. Mohseni SM,
   4. Sahraian MA,
   5. Montazeri A

   (2013) Determinants of sexual dysfunction in women with multiple sclerosis. BMC Neurol 13:83.

   OpenUrl
10. ↵
    1. Barak Y,
    2. Gabbay U,
    3. Glad R,
    4. Sarova-Pinhas I,
    5. Achiron A

    (1999) Neuropsychiatric assessment as a secondary outcome measure in a multiple sclerosis intravenous immunoglobulin L(IMg) trial. Int J Psychiatry Clin Pract 3:31–34.

    OpenUrl
11. ↵
    1. Marck CH,
    2. Neate SL,
    3. Taylor KL,
    4. Weiland TJ,
    5. Jelinek GA

    (2016) Prevalence of comorbidities, overweight and obesity in an international sample of people with multiple sclerosis and associations with modifiable lifestyle factors. PLoS One 11:e0148573.

    OpenUrlPubMed
12. ↵
    1. Wijenberg MLM,
    2. Stapert SZ,
    3. Köhler S,
    4. Bol Y

    (2016) Explaining fatigue in multiple sclerosis:cross-validation of a biopsychosocial model. J Behav Med 39:815–822.

    OpenUrl
13. ↵
    1. Solaro C,
    2. Trabucco E,
    3. Signori A,
    4. Martinelli V,
    5. Radaelli M,
    6. Centonze D,
    7. et al.

    (2016) Depressive symptoms correlate with disability and disease course in multiple sclerosis patients:an Italian multi-center study using the beck depression inventory. PLoS One 11:e0160261.

    OpenUrl
14. ↵
    1. Ryan JJ,
    2. Umfleet LG,
    3. Gontkovsky ST

    (2015) Prorating WAIS - IV summary scores for patients with relapsing-remitting multiple sclerosis. Int J Neurosci 126:1025–1029.

    OpenUrl
15. ↵
    1. Mohr DC,
    2. Goodkin DE,
    3. Gatto N,
    4. Van Der Wende J

    (1997) Depression, coping and level of neurological impairment in multiple sclerosis. Mult Scler J 3:254–258.

    OpenUrl
16. ↵
    1. Patten SB,
    2. Beck CA,
    3. Williams JVA,
    4. Barbui C,
    5. Metz LM

    (2003) Major depression in multiple sclerosis:A population-based perspective. Neurology 61:1524–1527.

    OpenUrlCrossRefPubMed
17. ↵
    1. Chen K,
    2. Fan Y,
    3. Hu R,
    4. Yang T,
    5. Li K

    (2012) Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis. Stress Heal 29:108–112.

    OpenUrl
18. ↵
    1. Čarnická Z,
    2. Kollár B,
    3. Šiarnik P,
    4. Krížová L,
    5. Klobučníková K,
    6. Turčáni P

    (2015) Sleep disorders in patients with multiple sclerosis. J Clin Sleep Med 11:553–557.

    OpenUrlPubMed
19. ↵
    1. Beck AT,
    2. Guth D,
    3. Steer RA,
    4. Ball R

    (1997) Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 35:785–791.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    1. Kos D,
    2. Kerckhofs E,
    3. Carrea I,
    4. Verza R,
    5. Ramos M,
    6. Jansa J

    (2005) Evaluation of the modified fatigue impact scale in four different European countries. Mult Scler J 11:76–80.

    OpenUrl
21. ↵
    1. Polman CH,
    2. Reingold SC,
    3. Banwell B,
    4. Clanet M,
    5. Cohen JA,
    6. Filippi M,
    7. et al.

    (2011) Diagnostic criteria for multiple sclerosis:2010 Revisions to the McDonald criteria. Ann Neurol 69:292–302.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    1. Strober,
    2. Lauren B

    (2015) “Fatigue in multiple sclerosis:a look at the role of poor sleep.” Frontiers in neurology 6:21.

    OpenUrl